Anti‐Coronaviral Nanocluster Restrain Infections of SARS‐CoV‐2 and Associated Mutants through Virucidal Inhibition and 3CL Protease Inactivation

Antivirals that can combat coronaviruses, including SARS‐CoV‐2 and associated mutants, are urgently needed but lacking. Simultaneously targeting the viral physical structure and replication cycle can endow antivirals with sustainable and broad‐spectrum anti‐coronavirus efficacy, which is difficult t...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Hao, Qin, Hongbo, He, Shiting, Li, Qizhen, Xu, Huan, Sun, Mengsi, Li, Jiaan, Lu, Shanshan, Luo, Shengdong, Mao, Panyong, Han, Pengjun, Song, Lihua, Tong, Yigang, Fan, Huahao, Jiang, Xingyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161070/
https://www.ncbi.nlm.nih.gov/pubmed/36843252
http://dx.doi.org/10.1002/advs.202207098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10161070/
https://www.ncbi.nlm.nih.gov/pubmed/36843252
http://dx.doi.org/10.1002/advs.202207098

Ejemplares similares